Publicaciones en colaboración con investigadores/as de University of Edinburgh (21)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616

2022

  1. A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes

    Journal of Biological Chemistry, Vol. 298, Núm. 8

  2. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

  3. Advances in mRNA-based drug discovery in cancer immunotherapy

    Expert Opinion on Drug Discovery, Vol. 17, Núm. 1, pp. 41-53

  4. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions

    Gut, Vol. 71, Núm. 8, pp. 1669-1683

  5. Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

    Cell death & disease, Vol. 13, Núm. 2, pp. 143

  6. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

  7. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures

    Gut, Vol. 71, Núm. 6, pp. 1141-1151

  8. Opportunities and challenges of bi-specific antibodies

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 45-70

2021

  1. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma

    Hepatology, Vol. 73, Núm. 6, pp. 2380-2396

  2. Fibrotic events in the progression of cholestatic liver disease

    Cells, Vol. 10, Núm. 5

  3. Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies

    Journal of Immunological Methods, Vol. 499

  4. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation

    Nature Genetics, Vol. 53, Núm. 9, pp. 1311-1321

2019

  1. Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link

    Cells, Vol. 8, Núm. 10

2017

  1. Novel urinary peptidomic classifier predicts incident heart failure

    Journal of the American Heart Association, Vol. 6, Núm. 8

  2. Recent progress in translational research on neurovascular and neurodegenerative disorders

    Restorative Neurology and Neuroscience, Vol. 35, Núm. 1, pp. 87-103

2012

  1. Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort

    European Respiratory Journal, Vol. 40, Núm. 1, pp. 177-184

2010

  1. Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: The European Early Lung Cancer Project

    International Journal of Oncology, Vol. 37, Núm. 2, pp. 455-461